Boston Scientific, Medtronic expected to quickly capture new atrial fibrillation market: analysts

The companies have acquired pulsed field ablation devices in recent years, but one surgeon told analysts he prefers Boston Scientific’s device as it doesn’t require general anesthesia, leading to faster patient turnaround.

Scroll to Top